Assay and Disintegration Testing for Zinc Sulphate Tablets
[Assay and Disintegration Testing for Zinc Sulphate Tablets]
EPTIS Ringversuch Nr. 1199146 | Letze Änderung 2024-08-21 | URL: https://www.eptis.bam.de/pts1199146 https://www.eptis.bam.de/pts1199146
| Name des Anbieters | ||||||||||||||||
| Name des Anbieters | Pharmaceutical Research and Development Lab, MUHAS Pharmaceutical Research and Development Lab, MUHAS | |||||||||||||||
| Ansässig in | Tanzania | |||||||||||||||
| Sprache(n) | English | |||||||||||||||
| Anmerkungen | PT services in the pharmaceutical sector the EAC Secretariat in co-operation with PTB, the German Metrology Institute, started to support Pharma R&D laboratory, to become a regional PT provider for pharmaceutical testing laboratories. So far nine (11) regional Proficiency Tests (PTs) on solid dosage forms have been undertaken. The last PT was on assay and disintegration of Amoxicillin capsules. All the labs were promptly notified and requested to carry out root cause analysis of their results. There after the participated lab were invited for training as part of CAPA and sharing their experience with fellow colleagues in the field. We 1have a strong confidentiality policy, in a way that all labs are coded and their results are not shared to a third party. Why proficiency Working with US? Our PT schemes are uniquely provided as we have a well-established pharmaceutical technology laboratory in which pharmaceutical samples with desired different strengths from that available on the market can be prepared to mask product strength to the participating laboratories. Participants can propose substance for the PT scheme based on the challenges they face in daily practices. | |||||||||||||||
| Klassifizierung | ||||||||||||||||
| Produktgruppen |
Pharmaceutical products, drugs
|
|||||||||||||||
| Prüfgebiete |
Analytical chemistry
|
|||||||||||||||
| Technische Einzelheiten | ||||||||||||||||
|
||||||||||||||||
| Ringversuchsziele | ||||||||||||||||
| Zielgruppe des Ringversuchs | African Pharmaceutical Testing Laboratories and Global | |||||||||||||||
| Relevante Rechtsvorschriften oder Normen | ISO 17043 | |||||||||||||||
| Weitere Ziele | validation of testing methods and also Competence assessment | |||||||||||||||
| Teilnehmerzahl | 50-200 | |||||||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch KENAS auf der Grundlage von ISO 17043 nicht für alle Parameter YES |
|||||||||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | ISO 17043 | |||||||||||||||
| Kosten | ||||||||||||||||
| Teilnahmegebühr | USD 100 | |||||||||||||||
| Regelmässig durchgeführt | Ja (EACH YEAR) | |||||||||||||||
| Der Ringversuch wird durchgeführt seit | 2013 | |||||||||||||||
| Kontaktdaten des Anbieters | ||||||||||||||||
| Anbieter | Kontaktperson | |||||||||||||||
|
Pharmaceutical Research and Development Lab, MUHAS
9-United Nation Road Dar Es Slaam Tanzania Telefon: +255754453847 Fax: Web: http://pharmrd.muhas.ac.tz/ http://pharmrd.muhas.ac.tz/ |
Mr Raphael Shedafa
Telefon: Fax: E-Mail: raphael.shedafa@gmail.com raphael.shedafa@gmail.com |
|||||||||||||||